Breast Cancer
Conditions
Interventions
All patients will receive a radioactive iodine seed (Bard Medical, Covington, USA) as per standard care, and the magnetic marker (Magseed, Endomag, Cambridge, UK). A radiologist will first implant the
however, it will only be used as a back-up for when localization through the magnetic probe is not possible or when the surgeon feels unsure about the location determined with the magnetic probe. Once
Sponsors
None
Eligibility
Inclusion criteria
Inclusion criteria: I. Female patients aged 18 years or older; II. Patients have biopsy-confirmed, unifocal, non-palpable breast cancer; III. Patients are eligible for breast-conserving surgery; IV. Patients did not undergo any neo-adjuvant treatment; V. Patients are willing and able to provide written informed consent.
Exclusion criteria
Exclusion criteria: I. The patient has a pacemaker.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure is retrieval rate of the magnetic marker using only the magnetic probe. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures are resection margins, collected from pathology reports and radiologist and surgeon satisfaction, determined through questionnaires. | — |
Contacts
Public ContactIris Noordhoek
Leids Universitair Medisch Centrum
Outcome results
None listed